# Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS

> **NCT07529197** · — · RECRUITING · sponsor: **Charite University, Berlin, Germany** · enrollment: 50 (estimated)

## Conditions studied

- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- ME/CFS Following COVID-19

## Interventions

- **DEVICE:** IA with TheraSorb ® column (Miltenyi)

## Key facts

- **NCT ID:** NCT07529197
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-11
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07529197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07529197, "Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07529197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*